Its cell-specific functions in cardiomyocytes, macrophages, and fibroblasts highlight HuR as a multifaceted regulator of cardiac pathology in metabolic disease contexts such as MASLD and T2DM. The gene discussed is ELAVL1; the disease is metabolic dysfunction-associated steatotic liver disease.